Clinical characteristics and treatment patterns of patients with muscle invasive bladder cancer: A real-world cohort study. Evaluation of avelumab first-line (1L) maintenance therapy and subsequent ...
Phase I/II canon study: Oncolytic immunotherapy for the treatment of non-muscle invasive bladder (NMIBC) cancer using intravesical coxsackievirus A21. This is an ASCO Meeting Abstract from the 2016 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results